LeMaitre Vascular Inc (LMAT)

Return on equity (ROE)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	44,038	41,319	37,680	33,952	30,105	27,267	25,221	20,638	20,636	21,184	22,232	27,016	26,907	27,765	28,774	23,975	21,220	18,800	16,471	17,595
Total stockholders’ equity	US$ in thousands	337,290	331,074	319,532	308,503	297,900	288,637	283,827	274,165	268,201	261,247	258,033	257,787	254,151	249,048	185,833	177,525	172,572	160,983	152,629	148,835
ROE		13.06%	12.48%	11.79%	11.01%	10.11%	9.45%	8.89%	7.53%	7.69%	8.11%	8.62%	10.48%	10.59%	11.15%	15.48%	13.51%	12.30%	11.68%	10.79%	11.82%

December 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $44,038K ÷ $337,290K
= 13.06%

LeMaitre Vascular Inc's return on equity (ROE) has exhibited fluctuations over the periods provided. The ROE increased steadily from March 31, 2020, to June 30, 2021, reflecting a positive trend in the company's profitability relative to shareholders' equity. However, starting from June 30, 2021, there was a notable decrease in ROE, with values falling below the peak achieved in June 2021. This decline continued until December 31, 2024, albeit with some fluctuations.

Overall, the ROE figures suggest that LeMaitre Vascular Inc has experienced periods of improving profitability in relation to shareholders' equity, but there was a subsequent decline in performance as indicated by the decreasing trend in ROE post-June 2021. It is important for stakeholders to further analyze the company's financial performance to understand the factors influencing these changes in ROE and to assess the sustainability of the company's profitability levels.